Medtronic
MDT
$90.39
Share price
0.96%
Change (1 day)
11.24%
Change (1 year)
Categories
Medtronic plc, headquartered in Dublin, is a listed company in the field of medical technology. The company is known for its pacemakers, implantable cardioverter defibrillators, heart valves, insulin pumps, aortic stent grafts, coronary stents and neurostimulators. Medtronic manufactures more than half of all pacemakers implanted worldwide.
Revenue for Medtronic (MDT)
Revenue in 2025 (TTM): $33.53 Billion USD
According to Medtronic's latest financial reports the company's current revenue (TTM 
) is $33.53 Billion USD. In 2024 the company made a revenue of $33.19 Billion USD an increase over the revenue in the year 2023 that were of $32.32 Billion USD. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Medtronic from 1996 to 2025
Annual revenue
| Year | Revenue | Change |
|---|---|---|
| 2025 (TTM) | $33.53 B | 1.02% |
| 2024 | $33.19 B | 2.72% |
| 2023 | $32.32 B | 5.03% |
| 2022 | $30.77 B | -3.19% |
| 2021 | $31.78 B | 13.82% |
| 2020 | $27.92 B | -10.1% |
| 2019 | $31.06 B | 1.66% |
| 2018 | $30.55 B | 2.79% |
| 2017 | $29.72 B | 1.24% |
| 2016 | $29.36 B | 2.77% |
| 2015 | $28.57 B | 63.05% |
| 2014 | $17.52 B | 3.68% |
| 2013 | $16.90 B | 2.88% |
| 2012 | $16.42 B | 1.51% |
| 2011 | $16.18 B | 2.88% |
| 2010 | $15.72 B | 1.8% |
| 2009 | $15.45 B | 5.61% |
| 2008 | $14.63 B | 13.1% |
| 2007 | $12.93 B | 7.03% |
| 2006 | $12.08 B | 9.85% |
| 2005 | $11.00 B | 10.67% |
| 2004 | $9.94 B | 16.01% |
| 2003 | $8.56 B | 17.25% |
| 2002 | $7.30 B | 19.09% |
| 2001 | $6.13 B | 12.28% |
| 2000 | $5.46 B | 16.96% |
| 1999 | $4.67 B | 25.43% |
| 1998 | $3.72 B | 34.05% |
| 1997 | $2.77 B | 16.11% |
| 1996 | $2.39 B |
Revenue for similar companies or competitors
| Company | Revenue | Revenue differencediff. | Country |
|---|---|---|---|
 Boston Scientific BSX | $17.55 B | -47.66% | 🇺🇸 USA |
 Stryker Corporation SYK | $23.21 B | -30.77% | 🇺🇸 USA |
 Edwards Lifesciences EW | $5.53 B | -83.48% | 🇺🇸 USA |
 Johnson & Johnson JNJ | $89.33 B | 166.37% | 🇺🇸 USA |
 Abbott Laboratories ABT | $42.34 B | 26.26% | 🇺🇸 USA |
 CONMED CNMD | $1.31 B | -96.08% | 🇺🇸 USA |
 Baxter BAX | $11.88 B | -64.55% | 🇺🇸 USA |
 Owens & Minor
OMI | $10.72 B | -68.03% | 🇺🇸 USA |
 Integra LifeSciences IART | $1.62 B | -95.16% | 🇺🇸 USA |